DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

METROPOLIS vs SURAKSHA: Stock Comparison

METROPOLIS HEALTHCARE vs SURAKSHA DIAGNOSTICUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

METROPOLIS HEALTHCARE is the larger company by market capitalisation. METROPOLIS HEALTHCARE shows lower leverage and a higher net margin, while SURAKSHA DIAGNOSTIC shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

METROPOLIS leads 6; SURAKSHA leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

METROPOLISSURAKSHA

Valuation lens

What price are you paying?

Market CapContext only
₹11,717 Cr
₹1,801 Cr
P/E RatioSURAKSHA has the lower reading
52.2x
43.06x ✓
P/B RatioSURAKSHA has the lower reading
7.13x
6.52x ✓
EPSMETROPOLIS has the higher reading
₹3.63 ✓
₹2.5
Book ValueContext only
₹73.49
₹46.75
Dividend YieldSURAKSHA has the higher reading
0.18%
0.29% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
METROPOLIS is the larger company
₹11,717 Cr vs ₹1,801 Cr
P/E Ratio
SURAKSHA has a lower P/E
43.06x vs 52.2x
P/B Ratio
SURAKSHA has a lower P/B
6.52x vs 7.13x
EPS
METROPOLIS has higher earnings per share
₹3.63 vs ₹2.5
Dividend Yield
SURAKSHA has a higher dividend yield
0.29% vs 0.18%
Revenue Growth (TTM YoY)
SURAKSHA has faster revenue growth
31.2% vs 23%
EPS Growth (TTM YoY)
METROPOLIS has faster EPS growth
73% vs -5.4%
Qtr Sales Growth
METROPOLIS has stronger quarterly sales growth
10.35% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMETROPOLISSURAKSHA
SectorHealthcareHealthcare
IndustryHealthcare Service ProviderHealthcare Service Provider

Price

MetricMETROPOLISSURAKSHA
Live Price₹564.2₹341.7
Day Change-0.18%0.21%
Volume1.96 L1.26 L
52-Week High₹2,060₹384
52-Week Low₹412.25₹224.1
Distance from 52W High-72.61%-11.02%

Valuation

MetricMETROPOLISSURAKSHA
Market Cap₹11,717 Cr₹1,801 Cr
P/E Ratio52.2x43.06x
P/B Ratio7.13x6.52x
EPS₹3.63₹2.5
Book Value₹73.49₹46.75
Dividend Yield0.18%0.29%

Growth

MetricMETROPOLISSURAKSHA
Revenue Growth (TTM YoY)23%31.2%
EPS Growth (TTM YoY)73%-5.4%
Qtr Sales Growth10.35%0%
Qtr Profit Growth32.7%0%

Profitability & Leverage

MetricMETROPOLISSURAKSHA
ROE11.31%13.64%
ROCE12.52%15.19%
Net Margin11.55%10.37%
Operating Margin16.88%19.81%
Debt to Equity0x0.01x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricMETROPOLISSURAKSHA
Promoter Holding47.82%▼ 1.04 pp49.1%
FII Holding11.67%▲ 0.64 pp13.97%▲ 0.5 pp
DII Holding35.49%▲ 0.37 pp21.56%▼ 1.67 pp
Public Holding5.02%▲ 0.03 pp15.37%▲ 1.16 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: METROPOLIS HEALTHCARE and SURAKSHA DIAGNOSTIC.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.